Background and objectives: Sudomotor impairment has been recognized as a key feature in differentiating Parkinson disease (PD) and multiple system atrophy-parkinsonian type (MSA-P) with the latter been characterized by diffuse anhidrosis in prospective study including patients in late stage of disease.We aimed to evaluate morphological and functional postganglionic sudomotor involvement in patients with new diagnosis MSA-P and PD to identify possible biomarkers that might be of help in differentiating the two conditions in early stage. Methods: One hundred patients with parkinsonism within 2 years from onset of motor symptoms were included in the study. At time of recruitment, questionnaires to assess non-motor, autonomic and small fiber sy...
Purpose: to assess phosphorylated α-synuclein (p-syn) deposits distribution in a patient affected by...
To evaluate the possibility that parkinsonian signs may be the only presenting feature of multiple s...
Clinical rationale for the study. Autonomic nervous system (ANS) involvement in different parkinsoni...
Background and objectives: Sudomotor impairment has been recognized as a key feature in differentiat...
Abstract OBJECTIVE: To evaluate postganglionic autonomic involvement in multiple system atrop...
Background: In Parkinson’s disease (PD), alpha-synuclein accumulation in cutaneous autonomic pilomot...
Objective: The prevalence of autonomic involvement in early stage of Parkinson 's disease (PD) is st...
Controversy remains regarding the thermoregulatory sweat function in Parkinson disease (PD) patients...
BACKGROUND: According to Braak staging of Parkinson's disease (PD), detection of autonomic dysfuncti...
Background: In Parkinson’s disease (PD), alpha-synuclein accumulation in cutaneous autonomic pilomo...
Objective To observe the sympathetic skin responses (SSR) in idiopathic Parkinson's disease (PD) and...
Background. It is often difficult to differentiate Parkinson’s disease (PD) from multiple system atr...
Background: Formal laboratory testing of autonomic function is reported to distinguish between patie...
Objective: To study small and large fiber pathology in drug-naive and l-dopa-treated patients affect...
Background: Possible pathophysiological mechanisms underlying Parkinson's disease (PD) clinical subt...
Purpose: to assess phosphorylated α-synuclein (p-syn) deposits distribution in a patient affected by...
To evaluate the possibility that parkinsonian signs may be the only presenting feature of multiple s...
Clinical rationale for the study. Autonomic nervous system (ANS) involvement in different parkinsoni...
Background and objectives: Sudomotor impairment has been recognized as a key feature in differentiat...
Abstract OBJECTIVE: To evaluate postganglionic autonomic involvement in multiple system atrop...
Background: In Parkinson’s disease (PD), alpha-synuclein accumulation in cutaneous autonomic pilomot...
Objective: The prevalence of autonomic involvement in early stage of Parkinson 's disease (PD) is st...
Controversy remains regarding the thermoregulatory sweat function in Parkinson disease (PD) patients...
BACKGROUND: According to Braak staging of Parkinson's disease (PD), detection of autonomic dysfuncti...
Background: In Parkinson’s disease (PD), alpha-synuclein accumulation in cutaneous autonomic pilomo...
Objective To observe the sympathetic skin responses (SSR) in idiopathic Parkinson's disease (PD) and...
Background. It is often difficult to differentiate Parkinson’s disease (PD) from multiple system atr...
Background: Formal laboratory testing of autonomic function is reported to distinguish between patie...
Objective: To study small and large fiber pathology in drug-naive and l-dopa-treated patients affect...
Background: Possible pathophysiological mechanisms underlying Parkinson's disease (PD) clinical subt...
Purpose: to assess phosphorylated α-synuclein (p-syn) deposits distribution in a patient affected by...
To evaluate the possibility that parkinsonian signs may be the only presenting feature of multiple s...
Clinical rationale for the study. Autonomic nervous system (ANS) involvement in different parkinsoni...